Bionano genomics announces publication of study from sorbonne universitÉ showing that wgs identified only 63% of structural variations that ogm detected in liver cancer

San diego, oct. 04, 2022 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced the publication of a study showing the use of optical genome mapping (ogm) to investigate a molecular subgroup of hepatocellular carcinoma (hcc), which is the most common form of liver cancer, in order to explore the complex structural variations (svs) induced by replication stress. in this study, ogm helped unravel replication stress-induced events, which may cause or contribute to genomic instability in cancer cells, potentially leading to the activation of oncogenes and disruption of tumor suppressors.
BNGO Ratings Summary
BNGO Quant Ranking